Isolda Romero-Canelón Selected Research

Platinum

5/2021	Organoruthenium Complexes with Benzo-Fused Pyrithiones Overcome Platinum Resistance in Ovarian Cancer Cells.
6/2019	Photoactive platinum(iv) complex conjugated to a cancer-cell-targeting cyclic peptide.
10/2018	In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance.
1/2018	Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action.
7/2015	Potent organo-osmium compound shifts metabolism in epithelial ovarian cancer cells.
10/2014	Potent Half-Sandwich Iridium(III) Anticancer Complexes Containing C∧N-Chelated and Pyridine Ligands.
11/2013	Next-generation metal anticancer complexes: multitargeting via redox modulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isolda Romero-Canelón Research Topics

Disease

26	Neoplasms (Cancer) 01/2023 - 02/2013
21	Ovarian Neoplasms (Ovarian Cancer) 03/2022 - 12/2012
4	Prostatic Neoplasms (Prostate Cancer) 03/2018 - 07/2015
3	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2014
2	Lung Neoplasms (Lung Cancer) 03/2022 - 05/2014
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 06/2015
1	Cystic Fibrosis (Mucoviscidosis) 12/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Bone Neoplasms (Bone Cancer) 01/2020
1	Carcinoma (Carcinomatosis) 10/2017
1	Phototoxic Dermatitis (Phototoxicity) 01/2017
1	Ovarian Epithelial Carcinoma 07/2015
1	Malaria 12/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2014

Drug/Important Bio-Agent (IBA)

20	Cisplatin (Platino)FDA LinkGeneric 03/2022 - 12/2012
8	LigandsIBA 05/2021 - 05/2014
7	PlatinumIBA 05/2021 - 11/2013
6	4-cymene (p-cymene)IBA 01/2023 - 02/2013
6	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 04/2014
6	OsmiumIBA 10/2019 - 11/2013
6	pyridineIBA 05/2018 - 02/2013
5	formic acid (formate)IBA 01/2023 - 03/2015
4	MetalsIBA 11/2018 - 11/2013
3	Buthionine SulfoximineIBA 03/2022 - 11/2013
3	RutheniumIBA 03/2018 - 11/2013
3	IridiumIBA 01/2018 - 11/2013
2	DNA (Deoxyribonucleic Acid)IBA 11/2019 - 11/2019
2	hydroxide ionIBA 06/2019 - 05/2014
2	NAD (NADH)IBA 05/2018 - 06/2015
2	CymenesIBA 01/2018 - 01/2017
1	AZD3965IBA 01/2023
1	Pyruvic Acid (Pyruvate)IBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	pyrithioneIBA 05/2021
1	Antineoplastic Agents (Antineoplastics)IBA 05/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2021
1	Polyketide SynthasesIBA 12/2020
1	TransferasesIBA 12/2020
1	glutarimideIBA 12/2020
1	NucleosidesIBA 01/2020
1	ThiosemicarbazonesIBA 11/2019
1	pyreneIBA 11/2019
1	PalladiumIBA 11/2019
1	ProdrugsIBA 10/2019
1	Cyclic PeptidesIBA 06/2019
1	polypeptide CIBA 06/2019
1	Succinic Acid (Succinate)IBA 06/2019
1	Amino Acids FDA Link 06/2019
1	Hydroxyl RadicalIBA 11/2018
1	OxidesIBA 11/2018
1	AnionsIBA 05/2018
1	EnzymesIBA 01/2018
1	N-Formylmethionine (Formylmethionine, N)IBA 01/2018
1	PolymersIBA 01/2018
1	AntioxidantsIBA 12/2017
1	LectinsIBA 10/2017
1	Canavalia lectinIBA 10/2017
1	Glutathione (Reduced Glutathione)IBA 01/2017
1	HydrogelsIBA 01/2017
1	Radioisotopes (Radionuclides)IBA 01/2017
1	Photosensitizing Agents (Photosensitizers)IBA 08/2016
1	Chlorpromazine (Thorazine)FDA Link 08/2016
1	TEMPOIBA 08/2016
1	Superoxides (Superoxide)IBA 07/2015
1	Proteins (Proteins, Gene)FDA Link 07/2015
1	N,N-dimethylanilineIBA 07/2015
1	9-methyladenineIBA 06/2015
1	9-ethylguanineIBA 06/2015
1	artemisinin (artemisinine)IBA 12/2014
1	TeaIBA 12/2014
1	AcidsIBA 12/2014
1	diphenyl (biphenyl)IBA 05/2014
1	Osmium CompoundsIBA 05/2014

Therapy/Procedure

3	Therapeutics 01/2018 - 07/2015
2	Synchrotrons 01/2018 - 02/2017
1	Drug Therapy (Chemotherapy) 01/2018
1	Self Medication 12/2014